Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Jason A. Willis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8238-8552; OpenAlex author ID A5064548744. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
47
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 3 papers · 2025: 1 paper · 2026: 2 papers

Papers 8

  1. Phase I trial of binimetinib plus hydroxychloroquine in patients with previously treated metastatic pancreatic cancer. Co-author DOI 10.1093/oncolo/oyag071↗
  2. Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1093/oncolo/oyag423↗
  3. KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13045-025-01696-0↗
  4. Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States. Co-author DOI 10.1002/cam4.7434↗
  5. Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41698-024-00505-0↗
  6. Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II T… Co-author DOI 10.1200/jco.24.00081↗
  7. Genome-wide analysis of the role of copy-number variation in pancreatic cancer risk. Co-author DOI 10.3389/fgene.2014.00029↗
  8. A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Co-author DOI 10.1158/1078-0432.ccr-11-2856↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert A. Wolff · 5 shared papers, 2024–2026 · strength 0.89
  2. Brandon George Smaglo · 5 shared papers, 2024–2026 · strength 0.89
  3. Shubham Pant · 5 shared papers, 2024–2026 · strength 0.89
  4. Matthew H. G. Katz · 5 shared papers, 2024–2026 · strength 0.82
  5. Michael James Overman · 4 shared papers, 2024–2026 · strength 0.75
  6. Anirban Maitra · 4 shared papers, 2024–2026 · strength 0.75
  7. Ryan W. Huey · 4 shared papers, 2024–2026 · strength 0.74
  8. Dan Zhao · 4 shared papers, 2024–2026 · strength 0.70
  9. Ethan Bernard Ludmir · 4 shared papers, 2024–2026 · strength 0.67
  10. Eugene Jon Koay · 4 shared papers, 2024–2026 · strength 0.67
  11. Naruhiko Ikoma · 3 shared papers, 2024–2026 · strength 0.52
  12. Abdelrahman M.G. Yousef · 3 shared papers, 2024–2026 · strength 0.52
  13. Saikat Chowdhury · 3 shared papers, 2024–2026 · strength 0.52
  14. Mahmoud Yousef · 3 shared papers, 2024–2026 · strength 0.52
  15. Rebecca Anne Snyder · 3 shared papers, 2024–2026 · strength 0.52
  16. Haoqiang Ying · 2 shared papers, 2025–2026 · strength 0.36
  17. Michael P. Kim · 2 shared papers, 2024–2025 · strength 0.33
  18. Ching-Wei David Tzeng · 2 shared papers, 2024–2025 · strength 0.33
  19. Suyu Liu · 2 shared papers, 2024 · strength 0.31
  20. Albert C. Koong · 2 shared papers, 2024 · strength 0.31
  21. Grace L. Smith · 2 shared papers, 2024 · strength 0.31
  22. Cullen M. Taniguchi · 2 shared papers, 2024 · strength 0.31
  23. Michael S. Lee · 2 shared papers, 2024 · strength 0.30
  24. J. Jack LEE · 1 shared paper, 2026 · strength 0.23
  25. Saurav Daniel Haldar · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.